Log in to save to my catalogue

Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors

Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1bf72d2d168c489c90f7ceab014ac31a

Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors

About this item

Full title

Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2018-10, Vol.9 (1), p.4347-11, Article 4347

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Arsenic trioxide (ATO) is a successful chemotherapeutic drug for blood cancers via selective induction of apoptosis; however its efficacy in solid tumors is limited. Here we repurpose nanodiamonds (NDs) as a safe and potent autophagic inhibitor to allosterically improve the therapeutic efficacy of ATO-based treatment in solid tumors. We find that N...

Alternative Titles

Full title

Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1bf72d2d168c489c90f7ceab014ac31a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1bf72d2d168c489c90f7ceab014ac31a

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-018-06749-2

How to access this item